Herbal preparations and “natural” dietary supplements are frequently used by patients with cardiovascular disease – often in the hope of “gently” influencing blood pressure, lipids or symptoms. However, guidelines from European and American professional societies unanimously emphasize that phytotherapeutics and dietary supplements should not replace established lifestyle and pharmacotherapy. In particular, the 2025 focused ESC/EAS update on dyslipidemia therapy concludes, after reviewing the available evidence, that there is insufficient evidence for any supplement that lowers LDL cholesterol while improving cardiovascular risk with reasonable safety.
Autoren
- Tanja Schliebe
Publikation
- PHYTOTHERAPIE PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Abdominal Pain – Von Meyenburg Complexes of the Liver
- Multiple sclerosis
Physical and psychosocial fatigue have the greatest impact on HRQoL
- Congenital Vascular Malformations
Personalized Treatment Before a Planned Pregnancy
- Hyperhidrosis: Keep a Cool Head
An Overview of Important Treatment Options
- This article was sponsored by Johnson & Johnson.
Give your patients a chance to live longer without progression with TECVAYLI® + DARZALEX® compared to DPd/DVd1
- Sjögren's Syndrome in Early Childhood
Children often develop lymphomas
- 2026 Vaccination Schedule: Important Changes
Updated Recommendations on Pneumococcal Disease and RSV
- Rare Genodermatoses: From Diagnosis to Treatment